It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a chronic disease with several degrees of histological features which may progress to cirrhosis. Obesity is an important risk factor and although NAFLD has no specific pharmacological treatment, bariatric surgery has been associated with NAFLD regression in severely obese patients. However, few longitudinal histological studies support this finding. Therefore, firstly, a retrospective study was performed including clinical and histological data of 895 obese patients who underwent bariatric surgery. In addition, histological analyses of 30 patient’s liver biopsies were evaluated at two timepoints (T1 and T2). The retrospective analysis of the total number of patients revealed that the average body mass index (BMI) was 35.91 ± 2.81 kg/m2. The liver biopsies during bariatric surgery showed that 53.52% did not present NAFLD, 30.16% had NASH, 15.98% isolated steatosis and 0.34% liver cirrhosis. The median BMI of the longitudinal cohort decreased from 37.9 ± 2.21 kg/m2 at the time of bariatric surgery (T1) to 25.69 ± 3.79 kg/m2 after 21 ± 22 months after the procedure (T2). The prevalence of NAFLD in T1 was 50%, and 16.67% in T2. The histological area of collagen fiber was lower in T2 compared to T1 (p = 0.0152) in the majority of patients, which was also illustrated by immunohistochemistry for Kupffer cell and myofibroblast formation markers. These findings confirmed the NAFLD regression after bariatric surgery and, for the first time, showed the amelioration of these features using more accurate histopathological techniques.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Campinas (UNICAMP), Department of Surgery, School of Medical Sciences, Campinas, Brazil (GRID:grid.411087.b) (ISNI:0000 0001 0723 2494); University of Campinas (UNICAMP), IBD Research Laboratory, School of Medical Sciences, Campinas, Brazil (GRID:grid.411087.b) (ISNI:0000 0001 0723 2494)
2 University of Campinas (UNICAMP), IBD Research Laboratory, School of Medical Sciences, Campinas, Brazil (GRID:grid.411087.b) (ISNI:0000 0001 0723 2494)
3 University of Campinas (UNICAMP), Department of Pathology, School of Medical Sciences, Campinas, Brazil (GRID:grid.411087.b) (ISNI:0000 0001 0723 2494)
4 University of Campinas (UNICAMP), Department of Surgery, School of Medical Sciences, Campinas, Brazil (GRID:grid.411087.b) (ISNI:0000 0001 0723 2494)
5 University of Campinas (UNICAMP), Laboratory of Metabolic Disorders, School of Applied Sciences, Limeira, Brazil (GRID:grid.411087.b) (ISNI:0000 0001 0723 2494)